Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-21-OPORP-CRA: DOD Orthotics and Prosthetics Outcomes, Clinical Research Award

Closed Closed July 29, 2021 Opportunity W81XWH-21-OPORP-CRA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2021.

• Total funding$15.0 million
• Expected awards4
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY21 OPORP CRA is intended to support clinical research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to Service Members, Veterans, and other individuals with limb loss and/or limb impairment. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical or policy decisions. The FY21 OPORP is also interested in multidisciplinary projects that address strategies to mitigate secondary injuries. Studies proposing or evaluating rehabilitation strategies must indicate how the rehabilitation may improve the orthotic or prosthetic device outcome when compared to standard of care. The FY21 OPORP CRA offers funding for two Funding Levels (Refer to Section II.D.5, Funding Restrictions). Only one Funding Level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of research appropriate for each Funding Level: • Funding Level 1 supports pilot and early-stage research studies that are exploratory and involve limited human exposure (e.g., small sample size), with the potential to make significant advancements toward clinical translation. Preliminary data are encouraged but not required for this Funding Level. • Funding Level 2 supports large clinical research projects that involve robust, statistically relevant participant numbers, with the potential to make significant advancement toward clinical translation. Proposed projects may include large-scale studies that, if successful, will generate high-quality outcomes that provide strong, definitive support for evidence-based practice and/or have the potential to drive changes in clinical practice. Pragmatic studies and comparative effectiveness studies are welcome and encouraged. Preliminary data relevant to the proposed clinical study are required for this Funding Level.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.